AI assistant
Sending…
ARIX BIOSCIENCE PLC — Director's Dealing 2018
Mar 21, 2018
4968_dirs_2018-03-21_b6748424-2a96-4cc8-a25c-2913a7b443f0.html
Director's Dealing
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 4574I
Arix Bioscience Plc
21 March 2018
21 March 2018
ARIX BIOSCIENCE PLC
Director/PDMR Shareholding
| PDMR DEALING NOTIFICATION | |||
| Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them | |||
| 1 | Details of the person discharging managerial responsibilities / person closely associated | ||
| a) | Name | Jonathan Peacock | |
| 2 | Reason for the notification | ||
| a) | Position / status | Chairman | |
| b) | Initial notification / Amendment |
Initial Notification | |
| 3 | Details of issuer | ||
| a) | Name | Arix Bioscience plc | |
| b) | LEI | 213800OVT3AHQCXNIX43 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Ordinary Shares of Arix Bioscience plc | |
| Identification code | GB00BD045071 | ||
| b) | Nature of the transaction | Purchase of Ordinary Shares | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| 225.00 pence | 90,000 | ||
| d) | Aggregated information | Aggregated price | Aggregated volume |
| N/A (single transaction) | N/A (single transaction) | ||
| e) | Date of the transaction | 20 March 2018 | |
| f) | Place of the transaction | London Stock Exchange (XLON) |
For further information:
James Rawlingson Chief Financial Officer +44 (0)207 290 1050
- Ends -
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHFFLFLVXFXBBD
More from ARIX BIOSCIENCE PLC
Delisting Announcement
2024
Feb 12
AGM Information
2024
Feb 12
Delisting Announcement
2024
Feb 12
M&A Activity
2024
Feb 7
Delisting Announcement
2024
Jan 29
AGM Information
2024
Jan 29
Major Shareholding Notification
2024
Jan 24
Proxy Solicitation & Information Statement
2024
Jan 23
AGM Information
2024
Jan 23
M&A Activity
2024
Jan 22